Arcus Biosciences (RCUS) EBT Margin (2017 - 2026)
Arcus Biosciences (RCUS) posted EBT Margin of -221.95% for Q2 2026, up 530.99 percentage points from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) EBT Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Arcus Biosciences was -393.16%, down 279.80 percentage points year-over-year; for FY2025, it was -142.91%, down 33.61 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of +14.78 percentage points (FY2020 to FY2025).
- In prior years, Arcus Biosciences' EBT Margin was -109.30% in FY2024 (+147.96 pp), -257.26% in FY2023 (-19.76 pp), -237.50% in FY2022 (-251.86 pp) and 14.36% in FY2021 (+172.05 pp).
- The Q2 2026 figure stands as the highest quarterly EBT Margin since Q3 2024.
- On a year-over-year basis, EBT Margin increased in two of the last six quarters, with an average year-over-year change of -186.16 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2021, with a gain of 627.46 percentage points; the weakest was Q3 2021, with a drop of 827.00 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -752.94% (Q1 2026), -321.21% (Q4 2025) and -519.23% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - | -221.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -221.95% |
| Mar 31, 2026 | -752.94% |
| Dec 31, 2025 | -321.21% |
| Sep 30, 2025 | -519.23% |
| Mar 31, 2025 | -400.00% |
| Dec 31, 2024 | -357.69% |
| Sep 30, 2024 | -191.67% |
| Jun 30, 2024 | -238.46% |
| Mar 31, 2024 | -2.76% |
| Dec 31, 2023 | -258.06% |
| Sep 30, 2023 | -215.63% |
| Jun 30, 2023 | -255.17% |
| Mar 31, 2023 | -312.00% |
| Dec 31, 2022 | -197.06% |
| Sep 30, 2022 | -196.97% |
| Jun 30, 2022 | -248.15% |
| Mar 31, 2022 | -372.22% |
| Dec 31, 2021 | 79.39% |
| Sep 30, 2021 | -824.17% |
| Jun 30, 2021 | -802.98% |
API Access
Arcus Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();